Oncology PracticeDenosumab Approved for Bone Loss From Hormone Ablation TherapySeptember 19, 2011Breast CancerGenitourinary CancerPatient & Survivor Care
Oncology PracticeEntinostat May Overcome AI Resistance in Breast CancerSeptember 14, 2011Breast Cancer
Oncology PracticeVenlafaxine, Clonidine Top Placebo for Breast Cancer Hot Flashes September 12, 2011Breast CancerPatient & Survivor Care
Oncology PracticeFDA Panel: Update Bisphosphonate LabelingSeptember 9, 2011Breast CancerPatient & Survivor Care
Oncology PracticeMeasure of Bone Metastases Predicts Breast Cancer SurvivalSeptember 9, 2011Breast Cancer
Oncology PracticeNew Nomograms Predict Lymphedema After Axillary Lymph Node DissectionSeptember 7, 2011Breast CancerPatient & Survivor Care
Oncology PracticeStudy Supports Palpation, Mammography Regardless of AgeSeptember 6, 2011Breast Cancer
The Journal of Community and Supportive OncologyMolecular tumor profile: another consideration for postmastectomy radiotherapySeptember 1, 2011Breast Cancer
Oncology PracticeU.K. Committee Calls Fulvestrant Unwise Use of ResourcesAugust 22, 2011Breast Cancer
Oncology PracticeUncertainty Rules Adjuvant Chemo for Early HER2 Breast Cancer August 16, 2011Breast Cancer
Oncology PracticeDual HER2 Blockade Strategies Advance in Breast Cancer TrialsAugust 9, 2011Breast Cancer
The Journal of Community and Supportive OncologyUnderstanding the estrogen receptor signaling PATHWAY: focus on current endocrine agents for breast cancer in postmenopausal womenAugust 1, 2011Breast Cancer
The Journal of Community and Supportive OncologyCommunity Oncology Podcast - Exemestane for preventing breast cancerJuly 31, 2011Breast CancerPreventive Care
Oncology PracticePoint/Counterpoint: Does Surgery Improve Survival in Stage IV Breast Cancer?July 28, 2011Breast Cancer
